Rémy Cointreau (RMC) Q1 24/25 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 TU earnings summary
3 Feb, 2026Executive summary
Q1 organic sales declined 15.6% year-over-year to €217 million, driven by continued de-stocking in the U.S., high base effects in APAC and EMEA, and soft global consumption amid strong promotional activity.
Volume fell 20.2%, partially offset by a 4.6% positive price/mix effect; Cognac was less impacted than Liqueurs and Spirits.
Americas saw a sharp sales decline due to ongoing de-stocking and weak demand; APAC was nearly flat with China stable and Japan strong; EMEA posted a double-digit drop, impacted by high comps and soft trends.
Financial highlights
Q1 sales were €217 million, down €40.5 million year-over-year (15.7% reported, 15.6% organic), with minimal currency impact.
Cognac sales fell 12.2% organically to €135.5 million; Liqueurs & Spirits dropped 20.4% to €75.8 million.
Partner/Non-group brands sales declined 24.6% organically.
Price-mix contributed +4.6% to group sales; volume effect was -20.2%.
Outlook and guidance
Full-year 2024-25 guidance confirmed, with gradual sales recovery expected as U.S. de-stocking concludes and APAC/EMEA comps normalize.
H1 to remain impacted by U.S. de-stocking, high APAC comps, and soft EMEA trends; H2 anticipated to recover, mainly led by the U.S.
Currency effects expected to negatively impact sales by €5–10 million, but positively impact operating profit by €3–7 million.
No sequential improvement expected in Q2; performance may be similar or worse than Q1.
Strategic plan targets high single-digit annual organic sales growth and gradual margin improvement by 2029-30.
Latest events from Rémy Cointreau
- Q3 organic sales up 2.8% as U.S. and EMEA gains offset APAC and China weakness.RMC
Q3 2026 TU3 Feb 2026 - Sales and profit dropped, but cost savings and recovery with high single-digit growth are targeted.RMC
H2 23/241 Feb 2026 - H1 sales dropped 15.9% organically, triggering revised guidance and a major cost-cutting plan.RMC
H1 24/25 TU18 Jan 2026 - Sales and profit dropped, but margins held up due to aggressive cost controls.RMC
H1 24/2512 Jan 2026 - Q3 sales fell 21.5% organically; full-year decline near 18% with margin guidance held.RMC
Q3 24/25 TU9 Jan 2026 - Sales fell 18% organically; margin guidance held, cost savings and tariff risks remain.RMC
Q4 24/25 TU29 Nov 2025 - Sales and profit declined, but transformation and investment in recovery continue.RMC
H1 25/2627 Nov 2025 - Sales and profit fell sharply, but cost savings and a US rebound support cautious optimism.RMC
H2 24/2521 Nov 2025 - H1 sales dropped 4.2% organically, prompting a guidance cut amid China and currency headwinds.RMC
Q2 25/26 TU31 Oct 2025